BamSEC and AlphaSense Join Forces
Learn More

Carisma Therapeutics Inc.

NASDAQ: CARM    
Share price (1/8/25): $0.47    
Market cap (1/8/25): $19.8 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 14 pages Master Services Agreement
12/34/56
EX-10.17
from 10-K 5 pages Carisma Therapeutics Inc. Stock Option Agreement
12/34/56
EX-10.18
from 10-Q 56 pages Lease ​ ​ by and Between ​ ​ ​ Wexford-Scec 3675 Market Street, LLC, a Delaware Limited Liability Company, Landlord ​ ​ and ​ ​ Carisma Therapeutics Inc., a Delaware Corporation, Tenant
12/34/56
EX-10.16
from 8-K 7 pages Carisma Therapeutics Inc. Amended and Restated 2014 Employee Stock Purchase Plan
12/34/56
EX-10.15
from 8-K 6 pages Carisma Therapeutics Inc. Restricted Stock Unit Agreement Granted Under the Amended and Restated 2014 Stock Incentive Plan
12/34/56
EX-10.14
from 8-K 5 pages Carisma Therapeutics Inc. Stock Option Agreement
12/34/56
EX-10.13
from 8-K 11 pages Carisma Therapeutics Inc. Amended and Restated 2014 Stock Incentive Plan
12/34/56
EX-10.12
from 8-K 9 pages Carisma Therapeutics Inc. Incentive Stock Option Agreement Granted Under 2017 Stock Incentive Plan
12/34/56
EX-10.11
from 8-K 9 pages Carisma Therapeutics Inc. Nonstatutory Stock Option Agreement Granted Under 2017 Stock Incentive Plan
12/34/56
EX-10.10
from 8-K 22 pages 2017 Stock Incentive Plan of Carma Therapeutics Inc
12/34/56
EX-10.9
from 8-K 20 pages Employment Agreement
12/34/56
EX-10.8
from 8-K 20 pages Employment Agreement
12/34/56
EX-10.7
from 8-K 21 pages Employment Agreement
12/34/56
EX-10.6
from 8-K 18 pages Indemnification Agreement
12/34/56
EX-10.5
from 8-K 19 pages Contingent Value Rights Agreement
12/34/56
EX-10.4
from 8-K 33 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 21 pages Voting and Support Agreement
12/34/56
EX-10.35
from S-4/A 28 pages Amended and Restated Subscription Agreement
12/34/56
EX-10.39
from S-4/A 22 pages 2017 Stock Incentive Plan of Carma Therapeutics Inc
12/34/56
EX-10.38
from S-4/A 11 pages Richard S. Morris ​ Dear Rich: On Behalf of Carisma Therapeutics, Inc., a Delaware Corporation (The “Company”), I Am Pleased to Offer You Employment With the Company. the Purpose of This Letter Is to Summarize the Terms of Your Employment With the Company, Should You Accept Our Offer
12/34/56